brand:
OZEMPIC®
manufacturer:
Novo Nordisk
active substances:
SEMAGLUTIDE
strength:
1mg
pack size:
1 pen, 4 disposable NovoFine® Plus needles (4 Doses)
OZEMPIC® 1mg (Italian) Indications for Use
OZEMPIC® 1mg (Italian) (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated for:
Limitations:
OZEMPIC® 1mg (Italian) is administered via a subcutaneous injection, typically once weekly. The injection can be taken at any time of day, with or without food. The initial dose is gradually increased to achieve better glycemic control:
OZEMPIC® 1mg (Italian) has several common and serious side effects. It’s important to monitor patients closely for any adverse reactions.
Several clinical trials support the efficacy of OZEMPIC® 1mg (Italian) in controlling blood sugar levels and reducing cardiovascular risks:
Renal and Hepatic Impairment: No dosage adjustment is necessary for patients with renal or hepatic impairment.